Pharmacogenetics: Mismatches between Policy and Practice

Abstract

Pharmacogenetics aims to improve the safety and efficacy of existing drugs and drugs under development. This paper explores existing mismatches between policy and practice and illustrates, through the case of an off-patent drug, how the use of personalised medicine is being shaped by user-producer mechanisms and negotiated between different actors involved in the process of drug development and service delivery.